Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating hallucinations and delusions associated with Parkinson's disease.

The broader outlook for the CDMO industry with small molecules is positive, and the management of Laurus Labs remains ...

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Bajaj Healthcare on Thursday said it has received approval from the Drug Controller General of India (DCGI) to manufacture a ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

I Pledge’ campaign engaged 4,350 doctors across six countries, setting a new benchmark in raising COPD awareness. Cipla ...

Companies in which DIIs and FIIs have decreased their holdings QoQ ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

News for Tata Consultancy Services Ltd. UBS Group Buys Shares in 29 Companies for Rs 1,938 Crore Swiss investment bank UBS Group acquired shares in 29 companies including Fortis Healthcare, Max ...

Rights Jan 31, 2018 Feb 01, 2018 Dec 20, 2017 Rights ratio: 2 share for every 25 held at a price of Rs 615.0 Rights Jan 31, 2018 Feb 01, 2018 Dec 19, 2017 Rights ratio: 4 share for every 25 held at a ...

Bonus Dec 03, 2024 Dec 03, 2024 Oct 17, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 06, 2019 Mar 07, 2019 Jan 18, 2019 Bonus Ratio: 1 share(s) for every 3 shares held Bonus Jun 13, ...